Analysis of anatomopathological results of radical prostatectomy specimen of patients who answer to criteria for active surveillance of prostate cancer;Analyse des résultats anatomopathologiques des pièces de prostatectomie radicale des patients répondant aux critères de surveillance active du cancer de prostate

Progres en Urologie

Volumn 19, Issue 9, 2009, Pages 619-623

  Azancot, V ^a   Peyromaure, M ^a   Xylinas, E ^a   Descazeaud, A ^b   Cornud, F ^a   Vieillefond, A ^a   Saighi, D ^a   Amsellem Ouazana, D ^a   Debre B ^a   Zerbib, M ^a  

^a hôpital Cochin ^*  (France)

^b LIMOGES UNIVERSITY HOSPITAL   (France)

Author keywords

Active surveillance; Prostate cancer; Radical prostatectomy

Indexed keywords

AGED; ARTICLE; HEALTH SURVEY; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PROSTATE TUMOR; PROSTATECTOMY; RETROSPECTIVE STUDY;

AGED; HUMANS; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; PROSTATECTOMY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES;

EID: 70349459757     PISSN: 11667087     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.purol.2009.05.011     Document Type: Article

References (20)

1. Greenlee R.T., Hill-Harmon M.B., Murray T., and Thun M. Cancer staistics, 2001. CA Cancer J Clin 51 (2001) 15-36
2. Cooperberg M.R., Lubeck D.P., Meng M.V., Mehta S.S., and Carroll P.R. The changing face of low-risk prostate cancer: trends in clinical presentation and primary management. J Clin Oncol 22 (2004) 2141-2149
3. Cooperberg M.R., Park S., and Carroll P.R. Prostate cancer 2004: insights from national disease registries. Oncology 18 (2004) 1239-1247
4. Albertsen P.C., Fryback D.G., Storer B.E., Kolon T.F., and Fine J. Long-term survival among men with conservatively treated localized prostate cancer. JAMA 274 (1995) 626-631
5. Johansson J.E., Holmberg L., Johansson S., Bergstrom R., and Adami H.O. Fifteen-year survival in prostate cancer. A prospective, population-based study in Sweden. JAMA 277 (1997) 467-471
6. Soulié M., Beuzeboc P., Cornud F., Eschwege P., Gaschignard N., Grosclaude P., et al. Cancer de la prostate. Prog Urol 17 (2007) 1159-1230
7. Suardi N., Capitanio U., Chun F.K., Graefen M., Perrotte P., Schlomm T., et al. Currently used criteria for active surveillance in men with low-risk prostate cancer. An analysis of pathologic features. Cancer 113 (2008) 2068-2072
8. Hardie C., Parker C., Norman A., et al. Early outcomes of active surveillance for localized prostate cancer. BJU Int 95 (2005) 956-960
9. Roemeling S., Roobol M.J., de Vries S.H., et al. Active surveillance for prostate cancers detected in 3 subsequent rounds of a screening trial: characteristics, PSA doubling times and outcome. Eur Urol 51 (2007) 1244-1250
10. Choo R., Klotz L., Danjoux C., et al. Feasibility study: watchful waiting for localized low to intermediate grade prostate carcinoma with selective delayed intervention based on prostate specific antigen, histological and/or clinical progression. J Urol 167 (2002) 1664-1669
11. Klotz L. Active surveillance for prostate cancer: for whom?. J Clin Oncol 23 (2005) 8165-8169
12. D'Amico A.V., and Coleman C.N. Role of interstitial radiotherapy in the management of clinically organ-confined prostate cancer: the jury is still out. J Clin Oncol 14 1 (1996) 304-315
13. Warlick C., Trock B.J., Landis P., Epstein J.I., and Carter H.B. Delayed versus immediate surgical intervention and prostate cancer. J Natl Cancer Inst 98 (2006) 355-357
14. Dall'Era M.A., Konety B.R., Cowan J.E., Shinohara K., Stauf F., Cooperberg M.R., et al. Active surveillance for the management of prostate cancer in a contemporary cohort. Cancer 112 (2008) 2664-2670
15. Berglund R.K., Masterson T.A., Vora K.C., Eggener S.E., Eastham J.A., and Guillonneau B.D. Pathological upgrading and upstaging with immediate repeat biopsy in patients eligible for active surveillance. J Urol 180 (2008 Nov) 1964-1967
16. Cabrera A.R., Coakley F.V., Westphalen A.C., Lu Y., Zhao S., Shinohara K., et al. Prostate cancer: is inapparent tumor at endorectal MR and MR spectroscopic imaging a favorable prognostic finding in patients who select active surveillance?. Radiology 247 (2008) 444-450
17. DeSouza N.M., Riches S.F., Vanas N.J., Morgan V.A., Ashley S.A., Fischr C., et al. Diffusion-weighted magnetic resonance imaging: a potential non-invasive marker of tumour aggressiveness in localized prostate cancer. Clin Radiol 63 (2008) 774-782
18. Chun FK, Suardi N, Capitanio U, Jeldres C, Ahyai S, Graefen M, et al. Assessment of pathological prostate cancer characteristics in men with favorable biopsy features on predominantly sextant biopsy. Eur Urol 2008:(consulté le 15 mai 2008).
19. Bill-Axelson A., Holmberg L., Ruutu M., Haggman M., Andersson S.O., Bratell S., et al. Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med 352 (2005) 1977-1984
20. Wong Y.N., Mitra N., Hudes G., Localio R., Schwartz J.S., Wan F., et al. Survival associated with treatment vs observation of localized prostate cancer in elderly men. JAMA 296 (2006) 2683-2693